当前位置: X-MOL 学术Scand. J. Clin. Lab. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Reproducibility of the CO rebreathing technique with a lower CO dose and a shorter rebreathing duration at sea level and at 2320 m of altitude.
Scandinavian Journal of Clinical and Laboratory Investigation ( IF 2.1 ) Pub Date : 2020-09-21 , DOI: 10.1080/00365513.2020.1818282
Laura Oberholzer 1 , Thomas Christian Bonne 1, 2 , Andreas Breenfeldt Andersen 2 , Jacob Bejder 2 , Regitse Højgaard Christensen 1 , Nikolai Baastrup Nordsborg 2 , Carsten Lundby 1, 3
Affiliation  

Abstract

Total hemoglobin mass (Hbmass) is routinely assessed in studies by the carbon monoxide (CO) rebreathing. Its clinical application is often hindered due to the consequent rise in carboxyhemoglobin (%HbCO) and the concern of CO toxicity. We tested the reproducibility of the CO rebreathing with a CO dose of 0.5 mL/kg body mass (CO0.5) compared to 1.5 mL/kg (CO1.5) and when shortening the CO rebreathing protocol. Therefore, CO rebreathing was performed 1×/day in eight healthy individuals on four consecutive days. On each day, either CO0.5 (CO0.5-1 and CO0.5-2) or CO1.5 (CO1.5-1 and CO1.5-2) was administered. Venous blood samples to determine %HbCO and quantify Hbmass were obtained prior to, and at 6 (T6), 8 (T8) and 10 min (T10) of CO rebreathing. This protocol was tested at sea level and at 2320 m to investigate the altitude-related measurement error. At sea level, the mean difference (95% limits of agreement) in Hbmass between CO0.5-1 and CO0.5-2 was 26 g (–26; 79 g) and between CO1.5-1 and CO1.5-2, it was 17 g (–18; 52 g). The respective typical error (TE) corresponded to 2.4% (CO0.5) and 1.5% (CO1.5), while it was 6.5% and 3.0% at 2320 m. With CO0.5, shortening the CO rebreathing resulted in a TE for Hbmass of 4.4% (T8 vs. T10) and 14.1% (T6 vs T10) and with CO1.5, TE was 1.6% and 5.8%. In conclusion, the CO dose and rebreathing time for the CO rebreathing procedure can be decreased at the cost of a measurement error ranging from 1.5-14.1%.



中文翻译:

CO 再呼吸技术的重现性,在海平面和海拔 2320 m 处具有较低的 CO 剂量和较短的再呼吸持续时间。

摘要

总血红蛋白质量 (Hb mass ) 在研究中通过一氧化碳 (CO) 再呼吸进行常规评估。由于碳氧血红蛋白 (%HbCO) 的升高和 CO 毒性的担忧,其临床应用往往受到阻碍。我们测试了 CO 再呼吸的重现性,CO 剂量为 0.5 mL/kg 体重 (CO 0.5 ) 与 1.5 mL/kg (CO 1.5 )相比,并在缩短 CO 再呼吸协议时。因此,连续四天对八名健康个体进行 1 次/天的 CO 再呼吸。每天,CO 0.5(CO 0.5 -1 和 CO 0.5 -2)或 CO 1.5(CO 1.5 -1 和 CO 1.5-2) 进行了管理。在 CO 再呼吸之前和 6 (T 6 )、8 (T 8 ) 和 10 分钟 (T 10 ) 时获得静脉血样本,以确定 %HbCO 和量化 Hb质量。该协议在海平面和 2320 m 处进行了测试,以调查与高度相关的测量误差。在海平面上,CO 0.5 -1 和 CO 0.5 -2之间Hb质量的平均差异(95% 一致限)为 26 g (–26; 79 g),CO 1.5 -1 和 CO 1.5 -2之间的平均差异为为 17 克(–18;52 克)各自的典型误差 (TE) 对应于 2.4% (CO 0.5 ) 和 1.5% (CO 1.5),而在 2320 m 处为 6.5% 和 3.0%。使用 CO 0.5 时,缩短 CO 再呼吸导致 Hb质量的TE 为4.4%(T 8与 T 10)和 14.1%(T 6与 T 10),使用 CO 1.5 时,TE 为 1.6% 和 5.8%。总之,可以减少 CO 再呼吸程序的 CO 剂量和再呼吸时间,代价是测量误差范围为 1.5-14.1%。

更新日期:2020-11-09
down
wechat
bug